A K Vine1. 1. University of Michigan Medical School, Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, Ann Arbor, Michigan, USA.
Abstract
PURPOSE: Previous studies have documented that an elevated plasma homocysteine level is a risk factor for vascular disease. The purpose of this study is to determine whether hyperhomocysteinemia is a risk factor for central retinal vein occlusion. METHODS: This case-controlled study involved reassessment of 74 patients with documented central retinal vein occlusion. Control subjects consisted of individuals referred to the same clinic for assessment of a nonretinal vascular disease. Hyperhomocysteinemia was defined as a total plasma homocysteine level above the 95th percentile in the control group. RESULTS: The mean total plasma homocysteine level was 11.58 mumol/L for cases and 9.49 mumol/L for controls. Of the 74 patients with a central retinal vein occlusion, 21.6% had total plasma homocysteine levels above the 95th percentile in the control group (odds ratio, 6.53; 95% confidence interval, 1.81 to 23.50, P = .003). Hyperhomocysteinemia was present in 55% of cases with bilateral disease, 30% of ischemic cases, and 31% of cases with severe visual loss. CONCLUSION: Hyperhomocysteinemia is a risk factor for central retinal vein occlusion.
PURPOSE: Previous studies have documented that an elevated plasma homocysteine level is a risk factor for vascular disease. The purpose of this study is to determine whether hyperhomocysteinemia is a risk factor for central retinal vein occlusion. METHODS: This case-controlled study involved reassessment of 74 patients with documented central retinal vein occlusion. Control subjects consisted of individuals referred to the same clinic for assessment of a nonretinal vascular disease. Hyperhomocysteinemia was defined as a total plasma homocysteine level above the 95th percentile in the control group. RESULTS: The mean total plasma homocysteine level was 11.58 mumol/L for cases and 9.49 mumol/L for controls. Of the 74 patients with a central retinal vein occlusion, 21.6% had total plasma homocysteine levels above the 95th percentile in the control group (odds ratio, 6.53; 95% confidence interval, 1.81 to 23.50, P = .003). Hyperhomocysteinemia was present in 55% of cases with bilateral disease, 30% of ischemic cases, and 31% of cases with severe visual loss. CONCLUSION:Hyperhomocysteinemia is a risk factor for central retinal vein occlusion.
Authors: M A Hofmann; B Kohl; M S Zumbach; V Borcea; A Bierhaus; M Henkels; J Amiral; W Fiehn; R Ziegler; P Wahl; P P Nawroth Journal: Diabetes Care Date: 1997-12 Impact factor: 19.112
Authors: K Robinson; K Arheart; H Refsum; L Brattström; G Boers; P Ueland; P Rubba; R Palma-Reis; R Meleady; L Daly; J Witteman; I Graham Journal: Circulation Date: 1998-02-10 Impact factor: 29.690
Authors: E B Rimm; W C Willett; F B Hu; L Sampson; G A Colditz; J E Manson; C Hennekens; M J Stampfer Journal: JAMA Date: 1998-02-04 Impact factor: 56.272
Authors: Ahra Cho; Sara D Ragi; Jin Kyun Oh; Jose Ronaldo Lima de Carvalho; Joseph Ryu; Ber-Yuh Yang; Stephen H Tsang Journal: Mol Genet Genomic Med Date: 2020-04-28 Impact factor: 2.183